Thiazolopyrimidines and their use as modulators of chemokine receptor activity
US6958343B2 · kind B2 · utility
5Cited by
24References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 2001 |
| Grant date | Oct 25, 2005 |
| Priority date | — |
| Expiry date | Feb 7, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I): are described herein. The compounds can be used, for example, in the treatment of chemokine mediated diseases, including inflammatory diseases such as psoriasis and COPD.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.